Background When a new pathogen, such as severe acute respiratory syndrome coronavirus 2, appears all novel information can aid in the process of monitoring and in the diagnosis of the coronavirus disease (COVID‐19). The aim of the current study is to elucidate the specific miRNA profile which can act as new biomarkers for distinguishing acute COVID-19 disease from the healthy group and those in the post-acute phase of the COVID-19 disease. Methods The expression level of selected miRNAs including let-7b-3p, miR-29a-3p, miR-146a-3p and miR-155-5p were evaluated in peripheral blood mononuclear cells (PBMCs) of COVID-19 patients, in both the acute and post-acute COVID-19 phase of the disease and healthy groups, by real-time PCR assays. Specificity and sensitivity of miRNAs was tested by receiver operating characteristic (ROC) analysis in COVID-19 patients. Results The expression level of all miRNAs in COVID-19 patients was significantly higher than in the healthy group. Therefore, the expression pattern of miR-29a-3p, miR-146a-3p and let-7b-3p in the post-acute COVID-19 phase was significantly different from the acute COVID-19 phase. ROC analyses demonstrated that miR-29a-3p, -155-5p and -146a-3p may serve as the novel biomarker for COVID-19 diagnosis with high specificity and sensitivity. In addition, miR-29a-3p, and -146a-3p can maybe act as novel biomarkers for distinguishing acute from post-acute phase of COVID-19 disease. Discussion The difference in miRNA expression pattern between COVID-19 patients and those in the healthy group, and between acute COVID-19 with post-acute COVID-19, suggested that cellular miRNAs could be used as promising biomarkers for diagnosis and monitoring of COVID-19.
【저자키워드】 COVID-19, SARS-CoV-2, Biomarker, microRNA, 【초록키워드】 coronavirus disease, coronavirus, miRNA, Diagnosis, COVID-19 disease, COVID‐19, Peripheral blood, sensitivity, specificity, ROC, pathogen, Real-time PCR, COVID-19 diagnosis, information, characteristic, disease, COVID-19 patients, ROC analysis, Analysis, PBMCs, COVID-19 patient, mononuclear cell, acute respiratory syndrome, expression level, acute COVID-19, miRNA expression, expression pattern, Result, selected, significantly, healthy, assays, addition, the disease, evaluated, appear, demonstrated, suggested, significantly higher, groups, cellular miRNA, diagnosis and monitoring, miRNA profile, the healthy, was tested, 【제목키워드】 PBMC, expression pattern,